Feb 28 (Reuters) - Amarin Corporation PLC AMRN.O :
- AMARIN AND CSL SEQIRUS ANNOUNCE EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENT TO COMMERCIALIZE VAZKEPA (ICOSAPENT ETHYL) IN AUSTRALIA AND NEW ZEALAND
- UNDER TERMS OF AGREEMENT, CSL SEQIRUS WILL IN-LICENSE VAZKEPA FROM AMARIN
- CSL SEQIRUS TO BE RESPONSIBLE FOR MARKET ACCESS, REIMBURSEMENT EFFORTS, DISTRIBUTION, FOR VAZKEPA ACROSS AUSTRALIA, NEW ZEALAND
- AMARIN WILL RECEIVE AN UPFRONT PAYMENT AND BE ELIGIBLE FOR EVENT-RELATED MILESTONE PAYMENTS OF UP TO APPROXIMATELY $8 MILLION
- AMARIN WILL RECEIVE ADDITIONAL PRODUCT-RELATED MILESTONE PAYMENTS OF UP TO APPROXIMATELY $4 MILLION
News: CSL Amarin And Csl Seqirus Announce Exclusive License And Distribution Agreement To...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$257.38 |
Change
8.990(3.62%) |
Mkt cap ! $124.6B | |||
| Open | High | Low | Value | Volume |
| $252.00 | $258.31 | $251.10 | $370.9M | 1.440M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 90 | $257.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $257.38 | 3331 | 1 |
View Market Depth
| Last trade - 16.11pm 18/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |